{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:04:45Z","timestamp":1771657485559,"version":"3.50.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.mehy.2009.01.025","type":"journal-article","created":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T04:28:11Z","timestamp":1237868891000},"page":"665-674","source":"Crossref","is-referenced-by-count":19,"title":["Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century"],"prefix":"10.1016","volume":"72","author":[{"given":"Kris G.","family":"McGrath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2009.01.025_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/er.19.4.365","article-title":"Breast and prostate cancer: an analysis of common epidemiological, common genetic and biochemical features","volume":"19","author":"L\u00f3pez-Ot\u00edn","year":"1998","journal-title":"Endocrinol Rev"},{"issue":"Suppl. 4A","key":"10.1016\/j.mehy.2009.01.025_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0090-4295(00)00938-9","article-title":"Similarities of prostate and breast cancer: evolution, diet, and estrogens","volume":"57","author":"Coffey","year":"2001","journal-title":"Urology"},{"issue":"Suppl. 6A","key":"10.1016\/j.mehy.2009.01.025_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2003.10.013","article-title":"Epidemiology of prostate cancer","volume":"62","author":"Crawford","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.mehy.2009.01.025_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/gyno.2001.6499","article-title":"Estrogen and cancer","volume":"86","author":"Creasman","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.mehy.2009.01.025_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2006.11.019","article-title":"Androgens and androgen receptors in breast cancer","volume":"105","author":"Diaz-Chico","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.mehy.2009.01.025_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jso.20722","article-title":"Androgens and androgen receptors: a clinically neglected sector in breast cancer biology","volume":"95","author":"Moe","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.mehy.2009.01.025_bib7","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/ijc.22363","article-title":"Increased expression of estrogen-related receptor \u03b1 (ERR\u03b1) is a negative prognostic predictor in human prostate cancer","volume":"120","author":"Fujimura","year":"2007","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.mehy.2009.01.025_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1369\/jhc.6A6927.2006","article-title":"Expression of enzymes involved in estrogen metabolism in human prostate","volume":"54","author":"Takase","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.mehy.2009.01.025_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jcb.240501224","article-title":"Hormonal balance and the risk of prostatic cancer","volume":"16H","author":"Isaacs","year":"1992","journal-title":"J Cell Biochem Suppl"},{"issue":"2","key":"10.1016\/j.mehy.2009.01.025_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0039-128X(92)90032-5","article-title":"Racial\/ethnic variations in male testosterone levels: a probable contributor to group differences in health","volume":"57","author":"Ellis","year":"1992","journal-title":"Steroids"},{"issue":"8798","key":"10.1016\/j.mehy.2009.01.025_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","article-title":"5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mehy.2009.01.025_bib12","first-page":"735","article-title":"Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada","volume":"4","author":"Wu","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.mehy.2009.01.025_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198709033171004","article-title":"The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia","volume":"317","author":"Peters","year":"1987","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.mehy.2009.01.025_bib14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1210\/mend-3-10-1515","article-title":"Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death","volume":"3","author":"Kyprianou","year":"1989","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.mehy.2009.01.025_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cr.2007.26","article-title":"Hormones and cancer","volume":"17","author":"Shang","year":"2007","journal-title":"Cell Research"},{"key":"10.1016\/j.mehy.2009.01.025_bib16","unstructured":"Heston JF, Kelly JB, Meigs, JW, et al. Forty-five years of cancer incidence in Connecticut: 1935\u20131979. In: Cusano MM, Young JL Jr, eds. Public Health Services, Monograph 70. National Institute of Health; 1986: p. 48\u20139, 352\u20133, 400\u2013401."},{"key":"10.1016\/j.mehy.2009.01.025_bib17","unstructured":"International Agency for Research on cancer: Combined estrogen\u2013progestogen contraceptives. In: Combined Estrogen\u2013progestogen Contraceptives and Combined Estrogen\u2013progestogen Menopausal Therapy, vol. 91. Lyon: International Agency for Research on Cancer; 2007: p. 42\u20135."},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2009.01.025_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cncr.11023","article-title":"Environmental risk factors for breast cancer among African-American women","volume":"97","author":"Wolff","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2009.01.025_bib19","unstructured":"US Department of Health and Human Services. Report on Carcinogens, 11th edition, Substance profiles: Estrogens, Steroidal, Public Health Service, and National Toxicology Program; 2005."},{"key":"10.1016\/j.mehy.2009.01.025_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/bcr1736","article-title":"Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin","volume":"9","author":"Colditz","year":"2007","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.mehy.2009.01.025_bib21","unstructured":"International Agency for Research on Cancer. Combined estrogen\u2013progestogen contraceptives. In: Combined estrogen\u2013progestogen contraceptives and combined estrogen\u2013progestogen menopausal therapy, vol. 91. Lyon: International Agency for Research on Cancer; 2007: 50\u201360."},{"key":"10.1016\/j.mehy.2009.01.025_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000077433","article-title":"Apolipoprotein E and the risk of breast cancer in African-American and non-Hispanic white women. A review","volume":"66","author":"Moore","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.mehy.2009.01.025_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"16","key":"10.1016\/j.mehy.2009.01.025_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast cancer incidence in 2003 in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.mehy.2009.01.025_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jnci\/82.8.693","article-title":"Rising incidence of breast cancer: relationship to stage and receptor status","volume":"82","author":"Glass","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.01.025_bib26","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","article-title":"Breast cancer incidence, 1980\u20132006: combined roles of menopausal hormone therapy, screening mammography, and estrogen status","volume":"99","author":"Glass","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.01.025_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5694\/j.1326-5377.1998.tb141472.x","article-title":"Prostate cancer in Western Australia: trends in incidence and mortality from 1985\u20131996","volume":"169","author":"Threlfall","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.mehy.2009.01.025_bib28","first-page":"7","article-title":"A rising incidence of prostate cancer in Australia: effect of \u201cscreening\u201d or more disease?","volume":"19","author":"McCredie","year":"1995","journal-title":"Cancer Forum"},{"key":"10.1016\/j.mehy.2009.01.025_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(94)91109-6","article-title":"Changes in prostate cancer incidence and treatment in USA","volume":"343","author":"Lu-Yao","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2009.01.025_bib30","first-page":"797","article-title":"Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989\u20131993","volume":"4","author":"Gilliland","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.mehy.2009.01.025_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00001648-199703000-00001","article-title":"Prostate cancer incidence and mortality rates among white and black men","volume":"8","author":"Merrill","year":"1997","journal-title":"Epidemiology"},{"key":"10.1016\/j.mehy.2009.01.025_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<99::AID-CNCR14>3.0.CO;2-1","article-title":"Trends in prostate carcinoma incidence in Connecticut (1988\u20131994) by age and race","volume":"79","author":"Polednak","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2009.01.025_bib33","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-5347(01)64231-9","article-title":"Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994","volume":"158","author":"Newcomer","year":"1997","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.025_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/j.1939-4640.2003.tb02676.x","article-title":"Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan","volume":"24","author":"Bhasin","year":"2003","journal-title":"J Androl"},{"key":"10.1016\/j.mehy.2009.01.025_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00114-003-0494-4","article-title":"The endocrine pharmacology of testosterone therapy in men","volume":"91","author":"Oettel","year":"2004","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.mehy.2009.01.025_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jsbmb.2006.09.032","article-title":"Prostate cancer risk in testosterone-treated men","volume":"102","author":"Raynaud","year":"2006","journal-title":"Steroid Biochem Mol Biol"},{"key":"10.1016\/j.mehy.2009.01.025_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J Natl Canc Inst"},{"key":"10.1016\/j.mehy.2009.01.025_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/oxfordjournals.epirev.a000795","article-title":"Hormones and prostate cancer: what\u2019s next?","volume":"23","author":"Hsing","year":"2001","journal-title":"Epidemiol Rev"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.025_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/djm329","article-title":"Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer","volume":"100","author":"Carpenter","year":"2008","journal-title":"J Natl Canc Inst"},{"key":"10.1016\/j.mehy.2009.01.025_bib40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","article-title":"Cutaneous androgen metabolism: Basic research and clinical perspectives","volume":"119","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.mehy.2009.01.025_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-14-1-121","article-title":"Androgen conjugates: Physiology and clinical significance","volume":"14","author":"Rittmaster","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mehy.2009.01.025_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-961807","article-title":"Sexual hormones in human skin","volume":"39","author":"Zouboulis","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.mehy.2009.01.025_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1034\/j.1600-0625.2002.110601.x","article-title":"The biological actions of estrogens on skin","volume":"11","author":"Thornton","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.mehy.2009.01.025_bib44","unstructured":"Food and Drug Administration. Department of Health and Human Services. Antiperspirant drug products for over-the-counter human use; final monograph. Federal Register 2003;68:34273\u201393."},{"key":"10.1016\/j.mehy.2009.01.025_bib45","first-page":"v","article-title":"Preface, Antiperspirants and deodorants: history of major HBA market, Antiperspirant technology trends from the patent literature","volume":"vol. 20","author":"Laden","year":"1999"},{"key":"10.1016\/j.mehy.2009.01.025_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008469-200312000-00006","article-title":"An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants\/deodorants and underarm shaving","volume":"12","author":"McGrath","year":"2003","journal-title":"Eur J Can Prev"},{"key":"10.1016\/j.mehy.2009.01.025_bib47","doi-asserted-by":"crossref","unstructured":"Rados C. Antiperspirant Awareness: it\u2019s Mostly No Sweat. U.S. Food and Drug administration. FDA Consumer magazine 2005: July\u2013August.","DOI":"10.1037\/e518172006-004"},{"key":"10.1016\/j.mehy.2009.01.025_bib48","unstructured":"Market Sizes. Historical forecast-volume consumption. Antiperspirants kg per \u2018000 people. Chicago, IL: Euromonitor International Inc.; 2008."},{"key":"10.1016\/j.mehy.2009.01.025_bib49","unstructured":"The US Cosmetics and Toiletries Market. Market studies. Raleigh, NC; 2009."},{"key":"10.1016\/j.mehy.2009.01.025_bib50","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.mehy.2006.09.039","article-title":"Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk","volume":"68","author":"Donovan","year":"2007","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.025_bib51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/89.3.188","article-title":"Why do African-American men suffer more from prostate cancer?","volume":"89","author":"McIntosh","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.01.025_bib52","unstructured":"SEER-Mortality rate higher for AA\u2019s\/BC&PC."},{"key":"10.1016\/j.mehy.2009.01.025_bib53","first-page":"365","volume":"38","author":"Homma","year":"1926","journal-title":"Johns Hopkins Hospital Bull"},{"key":"10.1016\/j.mehy.2009.01.025_bib54","first-page":"188","article-title":"Aging of the axillary apocrine sweat glands in the human female","volume":"vol. 2","author":"Montagna","year":"1956"},{"key":"10.1016\/j.mehy.2009.01.025_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejogrb.2004.08.010","article-title":"Human pheromones and sexual attraction","volume":"118","author":"Grammer","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.025_bib56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/mi.4.6.1","article-title":"Transdermal drug delivery: past present, future","author":"Scheindlin","year":"2004","journal-title":"Mol Interv"},{"key":"10.1016\/j.mehy.2009.01.025_bib57","unstructured":"State of Connecticut Department of Public Health. Connecticut Tumor Registry. Cancer Incidence in Connecticut 1980\u20131998; 2001: p. 18,21."},{"key":"10.1016\/j.mehy.2009.01.025_bib58","unstructured":"State of Connecticut Department of Public Health. Connecticut Tumor Registry. Cancer Incidence in Connecticut 2003; 2006: p. 10, 16."},{"key":"10.1016\/j.mehy.2009.01.025_bib59","unstructured":"State of Connecticut Department of Public Health. Connecticut Tumor Registry. Cancer Incidence in Connecticut 2005; 2007: p. 5, 11."},{"key":"10.1016\/j.mehy.2009.01.025_bib60","unstructured":"National Cancer Institute. Surveillance epidemiology and end results <http:\/\/www.cancer.gov\/>; [accessed 31.12.08]."},{"key":"10.1016\/j.mehy.2009.01.025_bib61","unstructured":"International Agency for Research on Cancer. Cancer incidence, mortality and prevalence worldwide. Globocan 2000. IARC Press; 2001 (CD-ROM)."},{"key":"10.1016\/j.mehy.2009.01.025_bib62","first-page":"25","article-title":"The history of antiperspirant product development","volume":"95","author":"Jass","year":"1980","journal-title":"Cosmet Toiletries"},{"key":"10.1016\/j.mehy.2009.01.025_bib63","first-page":"1","article-title":"The Magnitude of the breast cancer problem","volume":"vol. 57","author":"Cutler","year":"1976"},{"issue":"13","key":"10.1016\/j.mehy.2009.01.025_bib64","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jnci\/80.13.1076-a","article-title":"Changing incidence of breast cancer","volume":"80","author":"Glass","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.01.025_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0846.2007.00282.x","article-title":"Influence of climatic conditions on antiperspirant efficacy determined at different test areas","volume":"14","author":"Brandt","year":"2008","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.mehy.2009.01.025_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00418-004-0736-3","article-title":"Localization of steroid hormone receptors in the apocrine sweat glands of the human axilla","volume":"123","author":"Beier","year":"2005","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.mehy.2009.01.025_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4530(99)00056-6","article-title":"Behavioral and electrophysiologic effects of androstadienone, a human pheromone","volume":"25","author":"Grosser","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.mehy.2009.01.025_bib68","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/PL00000946","article-title":"Peroxisomes in the apocrine sweat glands of the human axilla and their putative role in pheromone production","volume":"58","author":"Rothardt","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mehy.2009.01.025_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsycho.2006.10.003","article-title":"Interpersonal defensive and diminished acuity for the odor of a putative pheromone: androstenone","volume":"74","author":"Kline","year":"2007","journal-title":"Biol Psyschol"},{"key":"10.1016\/j.mehy.2009.01.025_bib70","series-title":"Harrison\u2019s Endocrinology","first-page":"174","article-title":"Disorders of the ovary and female reproductive tract","author":"Carr","year":"2006"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.025_bib71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0960-0760(94)90082-5","article-title":"Comparison of 16-Androstene steroid concentrations in sterile apocrine sweat and axillary secretions: Interconversions of 16-Androstenes by axillary microflora-a mechanism for axillary odour production in man?","volume":"48","author":"Gower","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.mehy.2009.01.025_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbdv.200690015","article-title":"A broad diversity of volatile carboxylic acids, released by a bacterial aminoacylase from axilla secrecretions, as candidate molecules for the determination of human-body odor type","volume":"3","author":"Natsch","year":"2006","journal-title":"Chem Biodiversity"},{"issue":"8","key":"10.1016\/j.mehy.2009.01.025_bib73","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1074\/jbc.M210142200","article-title":"A specific bacterial aminoacyclase cleaves odorant precursors secreted in the human axilla","volume":"278","author":"Natsch","year":"2003","journal-title":"J Bio Chem"},{"key":"10.1016\/j.mehy.2009.01.025_bib74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00418-004-0736-3","article-title":"Localization of steroid hormone receptors in the apocrine sweat glands of the human axilla","volume":"123","author":"Konstantin","year":"2005","journal-title":"Histochem Cell Biol"},{"issue":"6","key":"10.1016\/j.mehy.2009.01.025_bib75","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1523\/JNEUROSCI.4430-06.2007","article-title":"Smelling a single component of male sweat alters levels of cortisol in women","volume":"27","author":"Wyart","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2009.01.025_bib76","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1098\/rspb.2005.3342","article-title":"The human brain is a detector of chemosensorily transmitted HLA-class I-similarity in same- and opposite-sex relations","volume":"B 273","author":"Pause","year":"2006","journal-title":"Proc R Soc"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.025_bib77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00224490409552244","article-title":"Pheromonal influences on sociosexual behavior in postmenopausal women","volume":"41","author":"Friebely","year":"2004","journal-title":"J Sex Res"},{"key":"10.1016\/j.mehy.2009.01.025_bib78","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuint.2003.10.003","article-title":"The putative pheromone androstadienone activates cortical fields in the human brain related to social cognition","volume":"44","author":"Gulyas","year":"2004","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.mehy.2009.01.025_bib79","first-page":"8","article-title":"Human pheromones","volume":"23","author":"Miller","year":"2006","journal-title":"Harv Ment Health Lett"},{"key":"10.1016\/j.mehy.2009.01.025_bib80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(98)01274-0","article-title":"Molecular aspects of pheromonal communication via the vomeronasal organ of mammals","volume":"21","author":"Tirindelli","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2009.01.025_bib81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev.ne.10.030187.001545","article-title":"The organization and function of the vomeronasal system","volume":"10","author":"Halpren","year":"1987","journal-title":"Ann Rev Neurosci"},{"key":"10.1016\/j.mehy.2009.01.025_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/79124","article-title":"A putative pheromone receptor gene expressed in human olfactory mucosa","volume":"26","author":"Rodriguez","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2009.01.025_bib83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1749-6632.1998.tb10595.x","article-title":"The human vomeronasal system: a review","volume":"855","author":"Monti-Bloch","year":"1998","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2009.01.025_bib84","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/(SICI)1097-0029(19980615)41:6<483::AID-JEMT4>3.0.CO;2-O","article-title":"Searching for the vomeronasal organ of adult humans: preliminary findings on location, structure and size","volume":"41","author":"Smith","year":"1998","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.mehy.2009.01.025_bib85","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0018-506X(86)90008-5","article-title":"Human axillary secretions influence women\u2019s menstrual cycles: the role of donor extract from men","volume":"20","author":"Cutler","year":"1986","journal-title":"Horm Behav"},{"key":"10.1016\/j.mehy.2009.01.025_bib86","series-title":"Sauer\u2019s manual of skin diseases","first-page":"6","article-title":"Structure of the skin","author":"Watson","year":"2006"},{"key":"10.1016\/j.mehy.2009.01.025_bib87","unstructured":"Elder DE, Elenitsas R, Johnson BL et al., eds. Lever\u2019s Histopathology of the Skin, 9th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2005: p. 33\u20137."},{"key":"10.1016\/j.mehy.2009.01.025_bib88","unstructured":"Dorland\u2019s Illustrated Medical Dictionary, 31st Edition. Philadelphia, PA: Saunders Elsevier; 2007: p. 118, 1840."},{"key":"10.1016\/j.mehy.2009.01.025_bib89","series-title":"Basic histology: text and atlas","first-page":"372","article-title":"The skin","author":"Junqueira","year":"2005"},{"key":"10.1016\/j.mehy.2009.01.025_bib90","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0039-128X(79)90077-1","article-title":"Steroid analysis of human apocrine secretion","volume":"34","author":"Labows","year":"1979","journal-title":"Steroids"},{"key":"10.1016\/j.mehy.2009.01.025_bib91","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jsbmb.2003.09.005","article-title":"Priduction of malodorous steroids from androstra-5, 16-dienes and androstra-4, 16-dienes by Corynebacteria and other human axillary bacteria","volume":"87","author":"Decreau","year":"2003","journal-title":"J steroid Biochem Mol Biol"},{"issue":"6","key":"10.1016\/j.mehy.2009.01.025_bib92","first-page":"1261","article-title":"Smelling a single component of male sweat alters levels of cortisol in women","volume":"27","author":"Wyart","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2009.01.025_bib93","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1472-765X.2004.01522.x","volume":"38","author":"Bojar","year":"2004","journal-title":"Letters in Applied Microbiology"},{"key":"10.1016\/j.mehy.2009.01.025_bib94","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000107575","article-title":"Percutaneous penetration enhancers: an overview","volume":"20","author":"Thong","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.mehy.2009.01.025_bib95","unstructured":"Products for Life Science Research. Sigma Life Science Catalog 2008\u20132009. Saint Louis, MO: Sigma-Aldrich, Inc.; 2008: p. 214\u2013215, 757\u2013760."},{"key":"10.1016\/j.mehy.2009.01.025_bib96","unstructured":"Physicians\u2019 Desk Reference, 62nd edition. Montvale, NJ: Thompson Healthcare Inc; 2008: p. 749, 833, 1904, 2221, 2352, 2390, 2725, 2986, 3038, 3134, 3358."},{"key":"10.1016\/j.mehy.2009.01.025_bib97","unstructured":"Physicians\u2019 Desk Reference, 62nd edition. Montvale, NJ: Thompson Healthcare Inc; 2004: p. 605, 2220."},{"key":"10.1016\/j.mehy.2009.01.025_bib98","unstructured":"<http:\/\/pubchem.ncbi.nlm.nih.gov\/summary\/summary.cgi?sid=6955> for Androstenediol [accesses 24.12.08]. PubChem Public Chemical Database."},{"key":"10.1016\/j.mehy.2009.01.025_bib99","unstructured":"<http:\/\/pubchem.ncbi.nlm.nih.gov\/summary\/summary.cgi?sid=6955> for Androstanediol MW [accessed 24.12.08]. Human Metabolome Database. Human Metabolome Project."},{"key":"10.1016\/j.mehy.2009.01.025_bib100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1677\/joe.0.0680483","article-title":"Occurrence of 5\u03b1-Androst-16-EN-3-ONE, A boar pheromone, in man and its relationship to testosterone","volume":"68","author":"Claus","year":"1976","journal-title":"J Endocrinol"},{"key":"10.1016\/j.mehy.2009.01.025_bib101","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1742-7843.2007.00165.x","article-title":"Does breast cancer start in the womb?","volume":"102","author":"Soto","year":"2008","journal-title":"Basic Clin Pharmacol"},{"key":"10.1016\/j.mehy.2009.01.025_bib102","unstructured":"National Center for Environmental Research. United States Environmental Protection Agency. What are endocrine disruptors? <http:\/\/www.es.epa.gov\/ncer\/science\/endocrine\/>; [accesses 01.01.09]. ADD AND ADJUST ACCORDINGLY."},{"key":"10.1016\/j.mehy.2009.01.025_bib103","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1742-7843.2007.00166.x","article-title":"Perinatal exposure to Oestradiol and Bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis","volume":"102","author":"Prins","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2009.01.025_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2004.10.017","article-title":"Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development","volume":"92","author":"Cunha","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.mehy.2009.01.025_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/bcr593","article-title":"The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer","volume":"5","author":"Lillie","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.mehy.2009.01.025_bib106","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jsbmb.2004.10.002","article-title":"The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer","volume":"92","author":"Platz","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.mehy.2009.01.025_bib107","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/bjc.1988.46","article-title":"The early in utero oestrogen and testosterone environment of blacks and whites: potential effects of male offspring","volume":"57","author":"Henderson","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2009.01.025_bib108","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10227-001-0152-4","article-title":"Long-term safety of spironolactone in acne: results of an 8-year followup study","volume":"6","author":"Shaw","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.mehy.2009.01.025_bib109","unstructured":"Environmental Working Group. Timeline: BPA from invention to phase-out. April 22, 2008. <http:\/\/www.ewg.org\/book\/export\/html\/26291> [accessed 22.11.08]."},{"key":"10.1016\/j.mehy.2009.01.025_bib110","unstructured":"Wilson MR. Cosmetic and hair products. The Electronic Encyclopedia of Chicago, Chicago Historical Society 2005. <http:\/\/www.encyclopedia.chicagohistory.org\/pages\/339.html> [accessed 22.11.08]."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T21:50:12Z","timestamp":1558216212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0306987709000784"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.01.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}